NeuroSense Therapeutics (NRSN) Cash & Equivalents (2020 - 2026)
NeuroSense Therapeutics (NRSN) reported Cash & Equivalents of $231,000 for Q2 2026, down 65.3% from $666,000 a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, NeuroSense Therapeutics posted Cash & Equivalents of $166,000, down 95.1% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -28.6% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $3.38 million in FY2024 (+28.0%), $2.64 million in FY2023 (-76.1%), $11.06 million in FY2022 (unchanged) and $11.06 million in FY2021.
- Five-year quarterly Cash & Equivalents spans a low of $166,000 in Q4 2025 and a high of $11.06 million in Q4 2022.
- Year over year, Cash & Equivalents gained in 1 of the last five quarters, with an average decline of 54.0%.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2022 (growth of 337.5%); the low point was Q4 2025 (a decline of 95.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | NeuroSense Therapeutics | 3.08 Mn | -1.36 Mn | - | 231,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 231,000.00 |
| Dec 31, 2025 | 166,000.00 |
| Jun 30, 2025 | 666,000.00 |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 344,000.00 |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 735,000.00 |
| Dec 31, 2023 | 2.64 Mn |
| Sep 30, 2023 | 4.76 Mn |
| Jun 30, 2023 | 7.09 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Sep 30, 2022 | 4.41 Mn |
| Jun 30, 2022 | 4.35 Mn |
| Mar 31, 2022 | 8.74 Mn |
| Dec 31, 2021 | 11.06 Mn |
| Dec 31, 2020 | 699,000.00 |
API Access
NeuroSense Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();